Arginase 1 antibody
GTX109242
ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetARG1
Overview
- SupplierGeneTex
- Product NameArginase 1 antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. IHC-Fr: 1:100-1:1000. FACS: 1:50-1:200. IP: 1:100-1:1000. ELISA: 1:1000-1:10000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.72 mg/ml
- ConjugateUnconjugated
- FormulationLiquid
- Gene ID383
- Target nameARG1
- Target descriptionarginase 1
- Target synonymsarginase, liver; arginase-1; liver-type arginase; type I arginase
- HostRabbit
- IsotypeIgG
- Protein IDP05089
- Protein NameArginase-1
- Scientific DescriptionArginase catalyzes the hydrolysis of arginine to ornithine and urea. At least two isoforms of mammalian arginase exist (types I and II) which differ in their tissue distribution, subcellular localization, immunologic crossreactivity and physiologic function. The type I isoform encoded by this gene, is a cytosolic enzyme and expressed predominantly in the liver as a component of the urea cycle. Inherited deficiency of this enzyme results in argininemia, an autosomal recessive disorder characterized by hyperammonemia. [provided by RefSeq]
- ReactivityHuman, Mouse, Rat
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Multi-Hit White Matter Injury-Induced Cerebral Palsy Model Established by Perinatal Lipopolysaccharide Injection. Liu L et al., 2022, Front PediatrRead more
- Grafted human ESC-derived astroglia repair spinal cord injury via activation of host anti-inflammatory microglia in the lesion area. Wang J et al., 2022, TheranosticsRead more
- Immunosuppressive Features of the Microenvironment in Lymph Nodes Granulomas from Tuberculosis and HIV-Co-Infected Patients. Ashenafi S et al., 2022 Apr, Am J PatholRead more
- FcgammaRIIB potentiates differentiation of myeloid-derived suppressor cells to mediate tumor immunoescape. Wu L et al., 2022, TheranosticsRead more
- Panobinostat enhances olaparib efficacy by modifying expression of homologous recombination repair and immune transcripts in ovarian cancer. Wilson AJ et al., 2022 Feb, NeoplasiaRead more
- Cryptotanshinone ameliorates CUS-induced depressive-like behaviors in mice. Wang K et al., 2021 Jan 1, Transl NeurosciRead more
- Potent but transient immunosuppression of T-cells is a general feature of CD71(+) erythroid cells. Grzywa TM et al., 2021 Dec 10, Commun BiolRead more
- The MEMIC is an ex vivo system to model the complexity of the tumor microenvironment. Janska L et al., 2021 Aug 1, Dis Model MechRead more
- Sevoflurane preconditioning protects experimental ischemic stroke by enhancing anti-inflammatory microglia/macrophages phenotype polarization through GSK-3beta/Nrf2 pathway. Cai M et al., 2021 Nov, CNS Neurosci TherRead more
- Positive effects of roflumilast on behavior, neuroinflammation, and white matter injury in mice with global cerebral ischemia. Vilhena ER et al., 2021 Sep 1, Behav PharmacolRead more